nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—ACAT1—hematopoietic system—thymus cancer	0.0307	0.0403	CbGeAlD
Sulfasalazine—TBXAS1—hematopoietic system—thymus cancer	0.0257	0.0337	CbGeAlD
Sulfasalazine—ACAT1—cardiac atrium—thymus cancer	0.0233	0.0306	CbGeAlD
Sulfasalazine—SLC46A1—hematopoietic system—thymus cancer	0.0229	0.03	CbGeAlD
Sulfasalazine—CHUK—hematopoietic system—thymus cancer	0.0229	0.03	CbGeAlD
Sulfasalazine—PLA2G1B—hematopoietic system—thymus cancer	0.0215	0.0282	CbGeAlD
Sulfasalazine—CHUK—epithelium—thymus cancer	0.0209	0.0275	CbGeAlD
Sulfasalazine—ACAT1—bone marrow—thymus cancer	0.0197	0.0258	CbGeAlD
Sulfasalazine—PLA2G1B—epithelium—thymus cancer	0.0197	0.0258	CbGeAlD
Sulfasalazine—ACAT1—thyroid gland—thymus cancer	0.0196	0.0258	CbGeAlD
Sulfasalazine—TBXAS1—lymphoid tissue—thymus cancer	0.0181	0.0237	CbGeAlD
Sulfasalazine—ACAT1—lung—thymus cancer	0.0178	0.0234	CbGeAlD
Sulfasalazine—SLC46A1—pituitary gland—thymus cancer	0.017	0.0223	CbGeAlD
Sulfasalazine—TBXAS1—bone marrow—thymus cancer	0.0164	0.0216	CbGeAlD
Sulfasalazine—TBXAS1—thyroid gland—thymus cancer	0.0164	0.0216	CbGeAlD
Sulfasalazine—CHUK—lymphoid tissue—thymus cancer	0.0161	0.0211	CbGeAlD
Sulfasalazine—SLC46A1—lymphoid tissue—thymus cancer	0.0161	0.0211	CbGeAlD
Sulfasalazine—PLA2G1B—pituitary gland—thymus cancer	0.0159	0.0209	CbGeAlD
Sulfasalazine—IKBKB—hematopoietic system—thymus cancer	0.0155	0.0204	CbGeAlD
Sulfasalazine—TBXAS1—lung—thymus cancer	0.0149	0.0196	CbGeAlD
Sulfasalazine—SLC46A1—thyroid gland—thymus cancer	0.0146	0.0192	CbGeAlD
Sulfasalazine—CHUK—thyroid gland—thymus cancer	0.0146	0.0192	CbGeAlD
Sulfasalazine—CHUK—lung—thymus cancer	0.0133	0.0174	CbGeAlD
Sulfasalazine—PPARG—neck—thymus cancer	0.013	0.0171	CbGeAlD
Sulfasalazine—ALOX5—hematopoietic system—thymus cancer	0.0129	0.0169	CbGeAlD
Sulfasalazine—PLA2G1B—lung—thymus cancer	0.0125	0.0164	CbGeAlD
Sulfasalazine—ACAT1—lymph node—thymus cancer	0.0122	0.016	CbGeAlD
Sulfasalazine—SLC7A11—thyroid gland—thymus cancer	0.012	0.0158	CbGeAlD
Sulfasalazine—CHUK—Canonical NF-kappaB pathway—CYLD—thymus cancer	0.012	0.0504	CbGpPWpGaD
Sulfasalazine—IKBKB—pituitary gland—thymus cancer	0.0115	0.0151	CbGeAlD
Sulfasalazine—SLCO1B1—hematopoietic system—thymus cancer	0.0112	0.0147	CbGeAlD
Sulfasalazine—IKBKB—lymphoid tissue—thymus cancer	0.0109	0.0144	CbGeAlD
Sulfasalazine—SLC7A11—lung—thymus cancer	0.0109	0.0144	CbGeAlD
Sulfasalazine—IKBKB—Canonical NF-kappaB pathway—CYLD—thymus cancer	0.0109	0.0457	CbGpPWpGaD
Sulfasalazine—TBXAS1—lymph node—thymus cancer	0.0102	0.0134	CbGeAlD
Sulfasalazine—IKBKB—thyroid gland—thymus cancer	0.00994	0.0131	CbGeAlD
Sulfasalazine—PPARG—hematopoietic system—thymus cancer	0.00967	0.0127	CbGeAlD
Sulfasalazine—CHUK—NOD1/2 Signaling Pathway—CYLD—thymus cancer	0.00948	0.0397	CbGpPWpGaD
Sulfasalazine—SLC46A1—lymph node—thymus cancer	0.00908	0.0119	CbGeAlD
Sulfasalazine—CHUK—lymph node—thymus cancer	0.00908	0.0119	CbGeAlD
Sulfasalazine—ALOX5—lymphoid tissue—thymus cancer	0.00907	0.0119	CbGeAlD
Sulfasalazine—IKBKB—lung—thymus cancer	0.00903	0.0119	CbGeAlD
Sulfasalazine—PPARG—epithelium—thymus cancer	0.00884	0.0116	CbGeAlD
Sulfasalazine—IKBKB—NOD1/2 Signaling Pathway—CYLD—thymus cancer	0.00859	0.036	CbGpPWpGaD
Sulfasalazine—ALOX5—bone marrow—thymus cancer	0.00826	0.0108	CbGeAlD
Sulfasalazine—ALOX5—thyroid gland—thymus cancer	0.00824	0.0108	CbGeAlD
Sulfasalazine—ALOX5—lung—thymus cancer	0.00748	0.00983	CbGeAlD
Sulfasalazine—CHUK—TNF receptor signaling pathway —CYLD—thymus cancer	0.00691	0.0289	CbGpPWpGaD
Sulfasalazine—PPARG—lymphoid tissue—thymus cancer	0.00681	0.00895	CbGeAlD
Sulfasalazine—CHUK—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CYLD—thymus cancer	0.00646	0.0271	CbGpPWpGaD
Sulfasalazine—IKBKB—TNF receptor signaling pathway —CYLD—thymus cancer	0.00627	0.0262	CbGpPWpGaD
Sulfasalazine—PPARG—bone marrow—thymus cancer	0.0062	0.00815	CbGeAlD
Sulfasalazine—PPARG—thyroid gland—thymus cancer	0.00618	0.00812	CbGeAlD
Sulfasalazine—IKBKB—lymph node—thymus cancer	0.00617	0.00811	CbGeAlD
Sulfasalazine—IKBKB—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CYLD—thymus cancer	0.00586	0.0245	CbGpPWpGaD
Sulfasalazine—CYP3A5—hematopoietic system—thymus cancer	0.00575	0.00756	CbGeAlD
Sulfasalazine—PPARG—lung—thymus cancer	0.00562	0.00738	CbGeAlD
Sulfasalazine—PTGS1—hematopoietic system—thymus cancer	0.00517	0.00679	CbGeAlD
Sulfasalazine—ALOX5—lymph node—thymus cancer	0.00512	0.00672	CbGeAlD
Sulfasalazine—PTGS2—hematopoietic system—thymus cancer	0.00494	0.00649	CbGeAlD
Sulfasalazine—PTGS1—epithelium—thymus cancer	0.00473	0.00621	CbGeAlD
Sulfasalazine—ABCG2—pituitary gland—thymus cancer	0.0046	0.00604	CbGeAlD
Sulfasalazine—PTGS2—epithelium—thymus cancer	0.00452	0.00593	CbGeAlD
Sulfasalazine—CHUK—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—CYLD—thymus cancer	0.00444	0.0186	CbGpPWpGaD
Sulfasalazine—IKBKB—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—CYLD—thymus cancer	0.00402	0.0169	CbGpPWpGaD
Sulfasalazine—ABCG2—bone marrow—thymus cancer	0.00397	0.00522	CbGeAlD
Sulfasalazine—ABCG2—thyroid gland—thymus cancer	0.00396	0.00521	CbGeAlD
Sulfasalazine—PTGS1—cardiac atrium—thymus cancer	0.00393	0.00516	CbGeAlD
Sulfasalazine—SLC46A1—Folate Metabolism—IL2—thymus cancer	0.00389	0.0163	CbGpPWpGaD
Sulfasalazine—PPARG—lymph node—thymus cancer	0.00384	0.00505	CbGeAlD
Sulfasalazine—PTGS1—pituitary gland—thymus cancer	0.00384	0.00504	CbGeAlD
Sulfasalazine—PTGS2—pituitary gland—thymus cancer	0.00367	0.00482	CbGeAlD
Sulfasalazine—ABCG2—lung—thymus cancer	0.0036	0.00473	CbGeAlD
Sulfasalazine—PTGS2—lymphoid tissue—thymus cancer	0.00348	0.00457	CbGeAlD
Sulfasalazine—ABCC2—lymph node—thymus cancer	0.00338	0.00444	CbGeAlD
Sulfasalazine—CYP3A5—lung—thymus cancer	0.00334	0.00439	CbGeAlD
Sulfasalazine—PTGS1—thyroid gland—thymus cancer	0.00331	0.00434	CbGeAlD
Sulfasalazine—PTGS2—bone marrow—thymus cancer	0.00317	0.00416	CbGeAlD
Sulfasalazine—CHUK—TCR signaling in naïve CD8+ T cells—CD8A—thymus cancer	0.00301	0.0126	CbGpPWpGaD
Sulfasalazine—PTGS1—lung—thymus cancer	0.003	0.00395	CbGeAlD
Sulfasalazine—PTGS2—lung—thymus cancer	0.00287	0.00377	CbGeAlD
Sulfasalazine—CHUK—Regulation of toll-like receptor signaling pathway—CYLD—thymus cancer	0.00285	0.0119	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR signaling in naïve CD8+ T cells—CD8A—thymus cancer	0.00273	0.0114	CbGpPWpGaD
Sulfasalazine—CHUK—AKT phosphorylates targets in the cytosol—AKT1—thymus cancer	0.00266	0.0111	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—DPYSL5—thymus cancer	0.00265	0.0111	CbGpPWpGaD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—CYLD—thymus cancer	0.00259	0.0108	CbGpPWpGaD
Sulfasalazine—SLC46A1—Folate Metabolism—TP53—thymus cancer	0.0025	0.0104	CbGpPWpGaD
Sulfasalazine—ABCG2—lymph node—thymus cancer	0.00246	0.00324	CbGeAlD
Sulfasalazine—CHUK—Downstream TCR signaling—CD4—thymus cancer	0.00213	0.0089	CbGpPWpGaD
Sulfasalazine—PTGS1—lymph node—thymus cancer	0.00205	0.0027	CbGeAlD
Sulfasalazine—CHUK—TCR Signaling Pathway—CD8A—thymus cancer	0.00197	0.00826	CbGpPWpGaD
Sulfasalazine—PTGS2—lymph node—thymus cancer	0.00196	0.00258	CbGeAlD
Sulfasalazine—IKBKB—Downstream TCR signaling—CD4—thymus cancer	0.00193	0.00807	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Fc-epsilon receptor I signaling in mast cells—AKT1—thymus cancer	0.00187	0.00784	CbGpPWpGaD
Sulfasalazine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—thymus cancer	0.00187	0.00784	CbGpPWpGaD
Sulfasalazine—CHUK—Validated transcriptional targets of TAp63 isoforms—CDKN2A—thymus cancer	0.00181	0.00758	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR Signaling Pathway—CD8A—thymus cancer	0.00179	0.00749	CbGpPWpGaD
Sulfasalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—thymus cancer	0.00178	0.00744	CbGpPWpGaD
Sulfasalazine—CHUK—Estrogen signaling pathway—AKT1—thymus cancer	0.00168	0.00705	CbGpPWpGaD
Sulfasalazine—PPARG—Regulation of retinoblastoma protein—CDKN2A—thymus cancer	0.00164	0.00688	CbGpPWpGaD
Sulfasalazine—IKBKB—Validated transcriptional targets of TAp63 isoforms—CDKN2A—thymus cancer	0.00164	0.00687	CbGpPWpGaD
Sulfasalazine—CHUK—TCR signaling—CD4—thymus cancer	0.00159	0.00665	CbGpPWpGaD
Sulfasalazine—CHUK—Constitutive PI3K/AKT Signaling in Cancer—KIT—thymus cancer	0.00154	0.00643	CbGpPWpGaD
Sulfasalazine—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—thymus cancer	0.00153	0.0064	CbGpPWpGaD
Sulfasalazine—IKBKB—Estrogen signaling pathway—AKT1—thymus cancer	0.00153	0.00639	CbGpPWpGaD
Sulfasalazine—CHUK—TCR signaling in naïve CD4+ T cells—CD4—thymus cancer	0.00145	0.00608	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR signaling—CD4—thymus cancer	0.00144	0.00603	CbGpPWpGaD
Sulfasalazine—CHUK—PI-3K cascade—KIT—thymus cancer	0.00138	0.00579	CbGpPWpGaD
Sulfasalazine—CHUK—PI3K/AKT activation—KIT—thymus cancer	0.00135	0.00566	CbGpPWpGaD
Sulfasalazine—CHUK—GAB1 signalosome—KIT—thymus cancer	0.00134	0.00561	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR signaling in naïve CD4+ T cells—CD4—thymus cancer	0.00132	0.00551	CbGpPWpGaD
Sulfasalazine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—thymus cancer	0.00131	0.00548	CbGpPWpGaD
Sulfasalazine—CHUK—Apoptosis—CDKN2A—thymus cancer	0.00127	0.00532	CbGpPWpGaD
Sulfasalazine—CHUK—FAS (CD95) signaling pathway—AKT1—thymus cancer	0.0012	0.00504	CbGpPWpGaD
Sulfasalazine—CHUK—Class I PI3K signaling events mediated by Akt—AKT1—thymus cancer	0.0012	0.00504	CbGpPWpGaD
Sulfasalazine—IKBKB—IL17 signaling pathway—AKT1—thymus cancer	0.0012	0.00503	CbGpPWpGaD
Sulfasalazine—ABCG2—Fluoropyrimidine Activity—TP53—thymus cancer	0.00116	0.00486	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis—CDKN2A—thymus cancer	0.00115	0.00483	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—MAML2—thymus cancer	0.00114	0.00475	CbGpPWpGaD
Sulfasalazine—CHUK—TCR Signaling Pathway—CD4—thymus cancer	0.00113	0.00474	CbGpPWpGaD
Sulfasalazine—IKBKB—FAS (CD95) signaling pathway—AKT1—thymus cancer	0.00109	0.00457	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis Modulation and Signaling—CDKN2A—thymus cancer	0.00108	0.00453	CbGpPWpGaD
Sulfasalazine—CHUK—TWEAK Signaling Pathway—AKT1—thymus cancer	0.00104	0.00436	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by SCF-KIT—KIT—thymus cancer	0.00103	0.00433	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR Signaling Pathway—CD4—thymus cancer	0.00103	0.0043	CbGpPWpGaD
Sulfasalazine—CHUK—Interleukin-11 Signaling Pathway—AKT1—thymus cancer	0.001	0.0042	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling of activated FGFR—KIT—thymus cancer	0.00099	0.00414	CbGpPWpGaD
Sulfasalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—thymus cancer	0.000988	0.00414	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB4—KIT—thymus cancer	0.000974	0.00408	CbGpPWpGaD
Sulfasalazine—IKBKB—TWEAK Signaling Pathway—AKT1—thymus cancer	0.000943	0.00395	CbGpPWpGaD
Sulfasalazine—PPARG—Wnt Signaling Pathway Netpath—AKT1—thymus cancer	0.000934	0.00391	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—KIT—thymus cancer	0.00093	0.0039	CbGpPWpGaD
Sulfasalazine—PPARG—Generic Transcription Pathway—MAML2—thymus cancer	0.00093	0.00389	CbGpPWpGaD
Sulfasalazine—PTGS2—C-MYB transcription factor network—KIT—thymus cancer	0.000927	0.00388	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—KIT—thymus cancer	0.000926	0.00388	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—KIT—thymus cancer	0.000921	0.00386	CbGpPWpGaD
Sulfasalazine—CHUK—FoxO family signaling—AKT1—thymus cancer	0.000919	0.00385	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—KIT—thymus cancer	0.000917	0.00384	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CYLD—thymus cancer	0.000914	0.00383	CbGpPWpGaD
Sulfasalazine—IKBKB—Interleukin-11 Signaling Pathway—AKT1—thymus cancer	0.000909	0.0038	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KIT—thymus cancer	0.000903	0.00378	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by Interleukins—IL2—thymus cancer	0.000901	0.00377	CbGpPWpGaD
Sulfasalazine—CHUK—TCR signaling in naïve CD8+ T cells—AKT1—thymus cancer	0.000863	0.00362	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—KIT—thymus cancer	0.000862	0.00361	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—KIT—thymus cancer	0.000862	0.00361	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—KIT—thymus cancer	0.000862	0.00361	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—KIT—thymus cancer	0.000855	0.00358	CbGpPWpGaD
Sulfasalazine—CHUK—IL-4 Signaling Pathway—AKT1—thymus cancer	0.000851	0.00356	CbGpPWpGaD
Sulfasalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—TP53—thymus cancer	0.000848	0.00355	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—KIT—thymus cancer	0.000847	0.00355	CbGpPWpGaD
Sulfasalazine—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—thymus cancer	0.000844	0.00353	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—KIT—thymus cancer	0.000843	0.00353	CbGpPWpGaD
Sulfasalazine—CHUK—RANKL/RANK Signaling Pathway—AKT1—thymus cancer	0.000838	0.00351	CbGpPWpGaD
Sulfasalazine—CHUK—IL-1 signaling pathway—AKT1—thymus cancer	0.000838	0.00351	CbGpPWpGaD
Sulfasalazine—CHUK—Cardiac Hypertrophic Response—AKT1—thymus cancer	0.000838	0.00351	CbGpPWpGaD
Sulfasalazine—IKBKB—FoxO family signaling—AKT1—thymus cancer	0.000834	0.00349	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CYLD—thymus cancer	0.000828	0.00347	CbGpPWpGaD
Sulfasalazine—CHUK—p75(NTR)-mediated signaling—TP53—thymus cancer	0.000828	0.00347	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KIT—thymus cancer	0.000819	0.00343	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by Interleukins—IL2—thymus cancer	0.000817	0.00342	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—KIT—thymus cancer	0.000798	0.00334	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR signaling in naïve CD8+ T cells—AKT1—thymus cancer	0.000783	0.00328	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—KIT—thymus cancer	0.000782	0.00327	CbGpPWpGaD
Sulfasalazine—CHUK—Fc-epsilon receptor I signaling in mast cells—AKT1—thymus cancer	0.000772	0.00323	CbGpPWpGaD
Sulfasalazine—IKBKB—IL-4 Signaling Pathway—AKT1—thymus cancer	0.000771	0.00323	CbGpPWpGaD
Sulfasalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—thymus cancer	0.000769	0.00322	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—KIT—thymus cancer	0.000764	0.0032	CbGpPWpGaD
Sulfasalazine—IKBKB—RANKL/RANK Signaling Pathway—AKT1—thymus cancer	0.00076	0.00318	CbGpPWpGaD
Sulfasalazine—IKBKB—Cardiac Hypertrophic Response—AKT1—thymus cancer	0.00076	0.00318	CbGpPWpGaD
Sulfasalazine—IKBKB—IL-1 signaling pathway—AKT1—thymus cancer	0.00076	0.00318	CbGpPWpGaD
Sulfasalazine—PTGS2—C-MYB transcription factor network—CDKN2A—thymus cancer	0.000753	0.00315	CbGpPWpGaD
Sulfasalazine—IKBKB—p75(NTR)-mediated signaling—TP53—thymus cancer	0.000751	0.00314	CbGpPWpGaD
Sulfasalazine—PPARG—SREBP signalling—AKT1—thymus cancer	0.000745	0.00312	CbGpPWpGaD
Sulfasalazine—CHUK—AGE/RAGE pathway—AKT1—thymus cancer	0.000724	0.00303	CbGpPWpGaD
Sulfasalazine—CHUK—TCR signaling in naïve CD4+ T cells—AKT1—thymus cancer	0.000724	0.00303	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—KIT—thymus cancer	0.000724	0.00303	CbGpPWpGaD
Sulfasalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—AKT1—thymus cancer	0.000716	0.003	CbGpPWpGaD
Sulfasalazine—CHUK—BCR signaling pathway—AKT1—thymus cancer	0.000716	0.003	CbGpPWpGaD
Sulfasalazine—PTGS2—C-MYB transcription factor network—CD4—thymus cancer	0.000709	0.00297	CbGpPWpGaD
Sulfasalazine—CHUK—Apoptosis—TP53—thymus cancer	0.000707	0.00296	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc-epsilon receptor I signaling in mast cells—AKT1—thymus cancer	0.0007	0.00293	CbGpPWpGaD
Sulfasalazine—CHUK—p75(NTR)-mediated signaling—AKT1—thymus cancer	0.000699	0.00293	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR signaling in naïve CD4+ T cells—AKT1—thymus cancer	0.000657	0.00275	CbGpPWpGaD
Sulfasalazine—IKBKB—AGE/RAGE pathway—AKT1—thymus cancer	0.000657	0.00275	CbGpPWpGaD
Sulfasalazine—IKBKB—mTOR signaling pathway—AKT1—thymus cancer	0.000657	0.00275	CbGpPWpGaD
Sulfasalazine—CHUK—Leptin signaling pathway—AKT1—thymus cancer	0.000654	0.00274	CbGpPWpGaD
Sulfasalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—AKT1—thymus cancer	0.000649	0.00272	CbGpPWpGaD
Sulfasalazine—IKBKB—BCR signaling pathway—AKT1—thymus cancer	0.000649	0.00272	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis—TP53—thymus cancer	0.000641	0.00269	CbGpPWpGaD
Sulfasalazine—IKBKB—p75(NTR)-mediated signaling—AKT1—thymus cancer	0.000634	0.00265	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis Modulation and Signaling—TP53—thymus cancer	0.000602	0.00252	CbGpPWpGaD
Sulfasalazine—CHUK—Apoptosis—AKT1—thymus cancer	0.000597	0.0025	CbGpPWpGaD
Sulfasalazine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—AKT1—thymus cancer	0.000597	0.0025	CbGpPWpGaD
Sulfasalazine—IKBKB—Leptin signaling pathway—AKT1—thymus cancer	0.000593	0.00248	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—KIT—thymus cancer	0.000587	0.00246	CbGpPWpGaD
Sulfasalazine—CHUK—Constitutive PI3K/AKT Signaling in Cancer—AKT1—thymus cancer	0.000586	0.00245	CbGpPWpGaD
Sulfasalazine—CHUK—TCR Signaling Pathway—AKT1—thymus cancer	0.000565	0.00237	CbGpPWpGaD
Sulfasalazine—ABCG2—HIF-1-alpha transcription factor network—AKT1—thymus cancer	0.000563	0.00236	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—IL2—thymus cancer	0.000562	0.00235	CbGpPWpGaD
Sulfasalazine—CHUK—TNF alpha Signaling Pathway—AKT1—thymus cancer	0.000555	0.00233	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis—AKT1—thymus cancer	0.000542	0.00227	CbGpPWpGaD
Sulfasalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—AKT1—thymus cancer	0.000542	0.00227	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—KIT—thymus cancer	0.000533	0.00223	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Receptor Signaling Pathway—AKT1—thymus cancer	0.000532	0.00223	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CYLD—thymus cancer	0.000532	0.00223	CbGpPWpGaD
Sulfasalazine—CHUK—PI-3K cascade—AKT1—thymus cancer	0.000528	0.00221	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—KIT—thymus cancer	0.000524	0.00219	CbGpPWpGaD
Sulfasalazine—CHUK—PI3K/AKT activation—AKT1—thymus cancer	0.000515	0.00216	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR Signaling Pathway—AKT1—thymus cancer	0.000513	0.00215	CbGpPWpGaD
Sulfasalazine—CHUK—Toll-like Receptor Signaling Pathway—AKT1—thymus cancer	0.000511	0.00214	CbGpPWpGaD
Sulfasalazine—CHUK—GAB1 signalosome—AKT1—thymus cancer	0.000511	0.00214	CbGpPWpGaD
Sulfasalazine—IKBKB—TNF alpha Signaling Pathway—AKT1—thymus cancer	0.000504	0.00211	CbGpPWpGaD
Sulfasalazine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—thymus cancer	0.0005	0.00209	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—IL2—thymus cancer	0.000497	0.00208	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Receptor Signaling Pathway—AKT1—thymus cancer	0.000483	0.00202	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CYLD—thymus cancer	0.000483	0.00202	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-like Receptor Signaling Pathway—AKT1—thymus cancer	0.000464	0.00194	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—MAML2—thymus cancer	0.000448	0.00187	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—TP53—thymus cancer	0.000442	0.00185	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD8A—thymus cancer	0.000428	0.00179	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—IL2—thymus cancer	0.00042	0.00176	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—CD4—thymus cancer	0.000401	0.00168	CbGpPWpGaD
Sulfasalazine—CHUK—Regulation of toll-like receptor signaling pathway—AKT1—thymus cancer	0.000399	0.00167	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by SCF-KIT—AKT1—thymus cancer	0.000395	0.00165	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MAML2—thymus cancer	0.00039	0.00163	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD8A—thymus cancer	0.000388	0.00163	CbGpPWpGaD
Sulfasalazine—CHUK—BDNF signaling pathway—AKT1—thymus cancer	0.000388	0.00163	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—IL2—thymus cancer	0.000381	0.0016	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling of activated FGFR—AKT1—thymus cancer	0.000378	0.00158	CbGpPWpGaD
Sulfasalazine—PPARG—Circadian rythm related genes—TP53—thymus cancer	0.000375	0.00157	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—AKT1—thymus cancer	0.000374	0.00156	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB4—AKT1—thymus cancer	0.000372	0.00156	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—TP53—thymus cancer	0.000368	0.00154	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	0.000367	0.00154	CbGpPWpGaD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—thymus cancer	0.000362	0.00152	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—TP53—thymus cancer	0.000361	0.00151	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—AKT1—thymus cancer	0.000355	0.00149	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—AKT1—thymus cancer	0.000353	0.00148	CbGpPWpGaD
Sulfasalazine—IKBKB—BDNF signaling pathway—AKT1—thymus cancer	0.000352	0.00147	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—AKT1—thymus cancer	0.000351	0.00147	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—AKT1—thymus cancer	0.00035	0.00146	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thymus cancer	0.000345	0.00144	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—KIT—thymus cancer	0.000335	0.0014	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—AKT1—thymus cancer	0.000329	0.00138	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	0.000329	0.00138	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—AKT1—thymus cancer	0.000329	0.00138	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—AKT1—thymus cancer	0.000326	0.00137	CbGpPWpGaD
Sulfasalazine—IKBKB—Insulin Signaling—AKT1—thymus cancer	0.000323	0.00135	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—AKT1—thymus cancer	0.000323	0.00135	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—AKT1—thymus cancer	0.000322	0.00135	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—KIT—thymus cancer	0.000322	0.00135	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TP53—thymus cancer	0.000319	0.00134	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thymus cancer	0.000313	0.00131	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—AKT1—thymus cancer	0.000311	0.0013	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	0.00031	0.0013	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—AKT1—thymus cancer	0.000305	0.00128	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—AKT1—thymus cancer	0.000305	0.00128	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—KIT—thymus cancer	0.000304	0.00127	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	0.000298	0.00125	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—KIT—thymus cancer	0.000292	0.00122	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	0.000291	0.00122	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—AKT1—thymus cancer	0.000276	0.00116	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MAML2—thymus cancer	0.000273	0.00114	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD8A—thymus cancer	0.00026	0.00109	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CD4—thymus cancer	0.000256	0.00107	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—AKT1—thymus cancer	0.000253	0.00106	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MAML2—thymus cancer	0.000248	0.00104	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD4—thymus cancer	0.000246	0.00103	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD8A—thymus cancer	0.000236	0.000987	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CD4—thymus cancer	0.000232	0.000973	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MAML2—thymus cancer	0.000231	0.000968	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—AKT1—thymus cancer	0.000224	0.000939	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD4—thymus cancer	0.000223	0.000934	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	0.000217	0.000909	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—AKT1—thymus cancer	0.000203	0.000851	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—AKT1—thymus cancer	0.0002	0.000837	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—KIT—thymus cancer	0.000195	0.000817	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—AKT1—thymus cancer	0.000192	0.000802	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	0.000183	0.000768	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—KIT—thymus cancer	0.00018	0.000754	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—KIT—thymus cancer	0.000177	0.000741	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—AKT1—thymus cancer	0.000167	0.000701	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—AKT1—thymus cancer	0.000154	0.000646	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD4—thymus cancer	0.000149	0.000625	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—AKT1—thymus cancer	0.00014	0.000585	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CD4—thymus cancer	0.000138	0.000577	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL2—thymus cancer	0.000137	0.000575	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD4—thymus cancer	0.000135	0.000567	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—AKT1—thymus cancer	0.000128	0.000535	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—KIT—thymus cancer	0.000126	0.000528	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL2—thymus cancer	0.000125	0.000521	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—AKT1—thymus cancer	0.000123	0.000514	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—AKT1—thymus cancer	0.000116	0.000485	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KIT—thymus cancer	0.000114	0.000479	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—AKT1—thymus cancer	0.000111	0.000466	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—KIT—thymus cancer	0.000107	0.000447	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—AKT1—thymus cancer	9.91e-05	0.000415	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL2—thymus cancer	8.88e-05	0.000372	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CD4—thymus cancer	8.16e-05	0.000342	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL2—thymus cancer	8.05e-05	0.000337	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—AKT1—thymus cancer	7.89e-05	0.00033	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—AKT1—thymus cancer	7.45e-05	0.000312	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—AKT1—thymus cancer	6.88e-05	0.000288	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—AKT1—thymus cancer	6.75e-05	0.000283	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—AKT1—thymus cancer	6.13e-05	0.000257	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TP53—thymus cancer	5.7e-05	0.000239	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TP53—thymus cancer	5.17e-05	0.000216	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—AKT1—thymus cancer	4.83e-05	0.000202	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—AKT1—thymus cancer	4.81e-05	0.000202	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—AKT1—thymus cancer	4.47e-05	0.000187	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—AKT1—thymus cancer	4.37e-05	0.000183	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—AKT1—thymus cancer	4.3e-05	0.00018	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—AKT1—thymus cancer	4.07e-05	0.000171	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—AKT1—thymus cancer	3.41e-05	0.000143	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—AKT1—thymus cancer	3.2e-05	0.000134	CbGpPWpGaD
